Nirmatrelvir combined with ritonavir for preventing and treating COVID‐19

Stefanie Reis; Maria Popp; Rebecca Kuehn; Maria Inti Metzendorf; Ildiko Gagyor; Peter Kranke; Patrick Meybohm; Nicole Skoetz; Stephanie Weibel

doi:10.1002/14651858.cd015395

Nirmatrelvir combined with ritonavir for preventing and treating COVID‐19

Stefanie Reis
, Maria Popp
, Rebecca Kuehn
, Maria Inti Metzendorf
, Ildiko Gagyor
, Peter Kranke
, Patrick Meybohm
, Nicole Skoetz
, Stephanie Weibel

Clinical Sciences

Research output: Contribution to journal › Review article › peer-review

35 Citations (Scopus)

Abstract

Objectives

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To assess the efficacy and safety of nirmatrelvir/ritonavir (Paxlovid®) plus standard of care compared to standard of care with or without placebo, or any other proven intervention for treating COVID‐19 and for preventing SARS‐CoV‐2 infection.

Original language	English
Article number	CD015395
Pages (from-to)	CD015395
Journal	Cochrane Database of Systematic Reviews
Volume	2022
Issue number	4
DOIs	https://doi.org/10.1002/14651858.cd015395
Publication status	Published - 11 Apr 2022

Access to Document

10.1002/14651858.cd015395

Reis et al-2022-Cochrane Database of Systematic ReviewsFinal published version, 257 KB

Cite this

@article{be83de5bdb4f4d99be78e3dfe896e8e0,

title = "Nirmatrelvir combined with ritonavir for preventing and treating COVID‐19",

abstract = "ObjectivesThis is a protocol for a Cochrane Review (intervention). The objectives are as follows:To assess the efficacy and safety of nirmatrelvir/ritonavir (Paxlovid{\textregistered}) plus standard of care compared to standard of care with or without placebo, or any other proven intervention for treating COVID‐19 and for preventing SARS‐CoV‐2 infection.",

author = "Stefanie Reis and Maria Popp and Rebecca Kuehn and Metzendorf, \{Maria Inti\} and Ildiko Gagyor and Peter Kranke and Patrick Meybohm and Nicole Skoetz and Stephanie Weibel",

year = "2022",

month = apr,

day = "11",

doi = "10.1002/14651858.cd015395",

language = "English",

volume = "2022",

pages = "CD015395",

journal = "Cochrane Database of Systematic Reviews",

issn = "1465-1858",

publisher = "John Wiley and Sons Ltd",

number = "4",

}

TY - JOUR

T1 - Nirmatrelvir combined with ritonavir for preventing and treating COVID‐19

AU - Reis, Stefanie

AU - Popp, Maria

AU - Kuehn, Rebecca

AU - Metzendorf, Maria Inti

AU - Gagyor, Ildiko

AU - Kranke, Peter

AU - Meybohm, Patrick

AU - Skoetz, Nicole

AU - Weibel, Stephanie

PY - 2022/4/11

Y1 - 2022/4/11

N2 - ObjectivesThis is a protocol for a Cochrane Review (intervention). The objectives are as follows:To assess the efficacy and safety of nirmatrelvir/ritonavir (Paxlovid®) plus standard of care compared to standard of care with or without placebo, or any other proven intervention for treating COVID‐19 and for preventing SARS‐CoV‐2 infection.

AB - ObjectivesThis is a protocol for a Cochrane Review (intervention). The objectives are as follows:To assess the efficacy and safety of nirmatrelvir/ritonavir (Paxlovid®) plus standard of care compared to standard of care with or without placebo, or any other proven intervention for treating COVID‐19 and for preventing SARS‐CoV‐2 infection.

U2 - 10.1002/14651858.cd015395

DO - 10.1002/14651858.cd015395

M3 - Review article

SN - 1465-1858

VL - 2022

SP - CD015395

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 4

M1 - CD015395

ER -

Nirmatrelvir combined with ritonavir for preventing and treating COVID‐19

Abstract

Access to Document

Fingerprint

Cite this